ADVFN - Advanced Financial Network.
HOME» NYSE » C » CAH Stock Price » CAH Stock News

Cardinal Health Share News

 Cardinal Health, Inc. Stock Price
CAH Stock Price
 Cardinal Health, Inc. Stock Chart
CAH Stock Chart
 Cardinal Health, Inc. Stock News
CAH Stock News
 Cardinal Health, Inc. Company Information
CAH Company Information
 Cardinal Health, Inc. Stock Trades
CAH Stock Trades

Cardinal Health 2Q Net Up 22% On Pharmaceutical Unit Strength

DOW JONES NEWSWIRES Cardinal Health Inc.'s (CAH) fiscal second-quarter earnings rose 22% on growth in its pharmaceuticals segment and higher margins, though the medical business posted weaker income. The second-biggest drug distributor in the U.S. behind McKesson Corp. (MCK) has continued to report stronger revenue, partly thanks to acquisitions. Cardinal has been acquisitive amid efforts to reduce its dependence on major customers such as CVS Caremark Corp. (CVS) and drug-store chain Walgreen Co.(WAG). Its more recent purchases include a diverse range of businesses, including China's largest pharmaceutical importer, a distributor of nursing-home supplies and a specialty pharmaceutical services company. For the quarter ended Dec. 31, Cardinal Health reported a profit of $262 million, or 75 cents a share, up from $215.4 million, or 61 cents a share, a year earlier. Excluding acquisition-related costs and other items, earnings from continuing operations rose to 81 cents from 73 cents. Revenue increased 6.7% to $27.08 billion. Analysts polled by Thomson Reuters most recently forecast earnings of 73 cents on revenue of $26.89 billion. Gross margin rose to 4.1% from 3.9%. The company's pharmaceutical segment's revenue grew 6.5%, and its profit rose 30% on acquisitions and increased volume from existing and new customers. The smaller medical business reported 9.4% higher revenue, but its profit declined 18% on commodity price pressure and increased investments in information systems. Shares closed Wednesday at $43.08 and were inactive premarket. The stock is down 1.7% over the past three months. -By Ben Fox Rubin, Dow Jones Newswires; 212-416-3108;;

Stock News for Cardinal Health (CAH)
11/19/201516:30:00Strong Results Reported for the Cordis INCRAFT® AAA Stent Graft...
11/18/201503:00:00Vigilant Biosciences Selects Cardinal Health as Global Third...
11/17/201516:14:26Statement of Changes in Beneficial Ownership (4)
11/17/201516:12:14Statement of Changes in Beneficial Ownership (4)
11/12/201508:46:06Statement of Changes in Beneficial Ownership (4)
11/09/201516:25:23Amended Current Report Filing (8-k/a)
11/06/201517:20:00Pharmacy Expert Shares Insights on New Reimbursement Programs...
11/05/201516:10:49Statement of Changes in Beneficial Ownership (4)
11/05/201516:09:58Statement of Changes in Beneficial Ownership (4)
11/05/201516:09:58Statement of Changes in Beneficial Ownership (4)
11/05/201516:09:58Statement of Changes in Beneficial Ownership (4)
11/05/201516:09:32Statement of Changes in Beneficial Ownership (4)
11/05/201516:09:06Statement of Changes in Beneficial Ownership (4)
11/05/201516:08:38Statement of Changes in Beneficial Ownership (4)
11/05/201516:07:48Statement of Changes in Beneficial Ownership (4)
11/05/201516:07:21Statement of Changes in Beneficial Ownership (4)
11/05/201516:06:58Statement of Changes in Beneficial Ownership (4)
11/04/201516:30:00Cardinal Health Announces Quarterly Dividend and Preliminary...
11/03/201516:17:08Quarterly Report (10-q)
11/02/201508:40:00Cardinal Health Raises Outlook, Profit Rises 44%

Cardinal Health and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations